Literature DB >> 9178890

rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral.

D R D'Adamo1, S Novick, J M Kahn, P Leonardi, A Pellicer.   

Abstract

A novel oncogene, rsc (rabbit squamous cell carcinoma), has been identified from a DMBA-induced rabbit squamous cell carcinoma using gene transfer and the nude mouse tumorigenesis assay. A full-length cDNA has been isolated and sequenced. rsc has potent tumorigenic activity in nude mice (latency <4 weeks), but does not induce focus formation or anchorage independent growth. The oncogene resulted from the fusion of rHR 23A (a rabbit homologue of yeast Rad 23) with a member of the ral-GDS family which we named rgr (ral-GDS related). Deletion analysis demonstrated that the oncogenic potential resides in the Rgr portion of the gene. Rgr is 40% identical overall to Ral-GDS, with identity increasing to 72% over a 100 amino acid region of the catalytic domain. Biochemical experiments indicate that Rgr has GTP/GDP exchange activity for Ral, providing evidence that this pathway is associated with tumorigenesis. The linkage between the Ral pathway and tumorigenesis by a molecule in the Ral-GDS gene family (Ral-GDS being a known effector for Ras) will open the way for the characterization of this pathway and provide an important tool to understand its biological function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178890     DOI: 10.1038/sj.onc.1200950

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 2.  All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.

Authors:  J L Bos
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

3.  Activation of the small GTPase Ral in platelets.

Authors:  R M Wolthuis; B Franke; M van Triest; B Bauer; R H Cool; J H Camonis; J W Akkerman; J L Bos
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).

Authors:  M Malumbres; I Pérez De Castro; M I Hernández; M Jiménez; T Corral; A Pellicer
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 5.  Regulating the regulator: post-translational modification of RAS.

Authors:  Ian M Ahearn; Kevin Haigis; Dafna Bar-Sagi; Mark R Philips
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

6.  Stimulation of gene induction and cell growth by the Ras effector Rlf.

Authors:  R M Wolthuis; N D de Ruiter; R H Cool; J L Bos
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

7.  An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.

Authors:  T Goi; M Shipitsin; Z Lu; D A Foster; S G Klinz; L A Feig
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

8.  Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins.

Authors:  N Movilla; X R Bustelo
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

9.  Ral activation promotes melanomagenesis.

Authors:  P A Zipfel; D C Brady; D F Kashatus; B D Ancrile; D S Tyler; C M Counter
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

Review 10.  Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.

Authors:  Leanna R Gentry; Timothy D Martin; David J Reiner; Channing J Der
Journal:  Biochim Biophys Acta       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.